If you take semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) and have noticed your skin not keeping up with your shrinking frame, you are not alone
In some individuals, particularly those following a low-carbohydrate diet or experiencing intercurrent illness, the body may produce ketones as it metabolises fat for energy
To a similar end, Endocrine News focuses on a few recent journal studies that take a closer look at the impacts of incretin-based therapies in the setting of obesity and impaired cardiovascular health, as well as how they affect the liver, quality of life, insulin resistance, and much more
Effects fade when you stop, and chasing permanence with continued high-dose injections is where the safety risk climbs